![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/17 | (2006.01) |
A61K 47/542 | (2017.08) | ||
A61K 47/54 | (2017.01) | ||
A61K 31/553 | (2013.01) | ||
A61K 38/18 | (2006.01) | ||
A61K 38/1709 | (2013.01) | ||
A61K 38/26 | (2006.01) | ||
A61K 47/545 | (2017.08) | ||
A61K 31/553 | (2006.01) | ||
A61K 47/54 | (2017.08) | ||
A61K 47/65 | (2017.01) | ||
A61K 47/65 | (2017.08) | ||
A61K 47/60 | (2017.01) | ||
A61K 47/60 | (2017.08) | ||
A61P 43/00 | (2006.01) | ||
A61K 38/18 | (2013.01) | ||
A61P 43/00 | (2018.01) | ||
A61K 38/26 | (2013.01) |
(11) | Number of the document | 2596805 |
(13) | Kind of document | T |
(96) | European patent application number | 13156350.4 |
Date of filing the European patent application | 2009-01-30 | |
(97) | Date of publication of the European application | 2013-05-29 |
(45) | Date of publication and mention of the grant of the patent | 2021-10-27 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
08150973 | 2008-02-01 | EP | |
08170872 | 2008-12-05 | EP |
(72) |
Cleemann, Felix , DE
Hersel, Ulrich , DE
Kaden-Vagt, Silvia , DE
Rau, Harald , DE
Wegge, Thomas , DE
|
(73) |
Ascendis Pharma A/S ,
Tuborg Boulevard 12, 2900 Hellerup,
DK
|
(54) | Prodrug comprising a drug-linker conjugate |
Prodrug comprising a drug-linker conjugate |